A multicentre, randomised clinical trial to evaluate the efficacy of oral ciprofloxacin, oral tamsulosin, and the combination of oral ciprofloxacin and oral tamsulosin for the treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
ISRCTN | ISRCTN85291415 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN85291415 |
Secondary identifying numbers | N/A |
- Submission date
- 30/06/2004
- Registration date
- 11/11/2004
- Last edited
- 25/08/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Kathleen Propert
Scientific
Scientific
University of Pennsylvania School of Medicine
Blockley Hall 6th Floor
423 Guardian Drive
Philadelphia, PA
19104-6021
United States of America
Study information
Study design | Multicentre randomised double blind placebo controlled 2x2 factorial trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study objectives | Not provided at time of registration |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) |
Intervention | A 2x2 factorial design assessing four interventions: ciprofloxacin alone, tamsulosin alone, the combination of ciprofloxacin and tamsulosin, and placebo. All treatments were provided for six weeks. Please note that as of 25/08/09 the start and end dates of this trial have been updated. The initial dates, 01/04/2002 to 30/04/2004, were generated at the time of registration. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Ciprofloxacin, tamsulosin |
Primary outcome measure | Not provided at time of registration |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/07/2001 |
Completion date | 30/09/2002 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Male |
Target number of participants | 184 (196 final [added 25/08/09]) |
Key inclusion criteria | Approximately 184 participants, 46 per arm, were treated and followed for a total of 12 weeks. These participants were male, had symptoms of discomfort or pain in the pelvic region for at least a 3 month period within the last 6 months, and had a overall score of equal to or greater than 15 out of 43 points on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Total Score. |
Key exclusion criteria | Does not match inclusion criteria |
Date of first enrolment | 01/07/2001 |
Date of final enrolment | 30/09/2002 |
Locations
Countries of recruitment
- United States of America
Study participating centre
University of Pennsylvania School of Medicine
Philadelphia, PA
19104-6021
United States of America
19104-6021
United States of America
Sponsor information
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIDDK, NIH) (USA)
Research organisation
Research organisation
Dr John W. Kusek
2 Democracy Plaza
Room 617
6707 Democracy Boulevard
Bethesda, MD
20892-5458
United States of America
Website | http://www.niddk.nih.gov |
---|---|
https://ror.org/00adh9b73 |
Funders
Funder type
Government
National Institutes of Health (NIH) (USA) - cooperative agreements U01 DK53572, U01 DK53730, U01 DK53736, U01 DK53734, U01 DK53732, U01 DK53746, and U01 DK53738.
No information available
Boehringer Ingelheim (USA) - provided tamsulosin and matching placebo
No information available
Bayer Corporation (USA) - provided ciprofloxacin and matching placebo.
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 19/10/2004 | Yes | No |